VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 11, 2023

Total Value ($000): $625,361 (100.0% shares, 0.0% debt)

Holdings (30)

VRDN VIRIDIAN THERAPEUTICS INC 11.7%
Value ($000) $73,336 Shares 3,082,622 Est. Cost $20.23 Unrealized +26.8%
COGT COGENT BIOSCIENCES INC 8.9%
Value ($000) $55,460 Shares 4,684,132 Est. Cost $8.79 Unrealized +30.6%
FDMT 4D MOLECULAR THERAPEUTICS IN 8.7%
Value ($000) $54,210 Shares 3,000,000 Est. Cost $18.41 Unrealized 0.0%
ELVN ENLIVEN THERAPEUTICS INC 7.3%
Value ($000) $45,517 Shares 2,230,127 Est. Cost $20.34 Unrealized -0.6%
MERUS N V 7.3%
Value ($000) $45,451 Shares 1,726,214 Est. Cost $18.62 Unrealized
GHRS GH RESEARCH PLC 6.7%
Value ($000) $41,731 Shares 3,517,125 Est. Cost $17.34 Unrealized -40.8%
AMBRX BIOPHARMA INC 6.5%
Value ($000) $40,902 Shares 2,484,960 Est. Cost $8.92 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 4.2%
Value ($000) $26,250 Shares 2,916,667 Est. Cost $5.36 Unrealized +72.1%
TERN TERNS PHARMACEUTICALS INC 4.2%
Value ($000) $26,013 Shares 2,972,869 Est. Cost $3.72 Unrealized +213.7%
CABA CABALETTA BIO INC 4.1%
Value ($000) $25,475 Shares 1,973,251 Est. Cost $3.87 Unrealized +180.7%
DYN DYNE THERAPEUTICS INC 3.9%
Value ($000) $24,457 Shares 2,173,913 Est. Cost $11.80 Unrealized 0.0%
CELC CELCUITY INC 3.7%
Value ($000) $23,117 Shares 2,105,386 Est. Cost $10.24 Unrealized +1.5%
SVRA SAVARA INC 3.2%
Value ($000) $20,293 Shares 6,351,531 Est. Cost $1.32 Unrealized +78.3%
PHVS PHARVARIS N V 3.2%
Value ($000) $20,079 Shares 1,326,200 Est. Cost $9.62 Unrealized 0.0%
RYTM RHYTHM PHARMACEUTICALS INC 2.9%
Value ($000) $17,974 Shares 1,090,000 Est. Cost $18.05 Unrealized 0.0%
ORIC ORIC PHARMACEUTICALS INC 2.7%
Value ($000) $16,629 Shares 2,142,856 Est. Cost $5.68 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 1.7%
Value ($000) $10,793 Shares 1,040,754 Est. Cost $13.57 Unrealized -33.3%
TRVI TREVI THERAPEUTICS INC 1.3%
Value ($000) $8,180 Shares 3,422,397 Est. Cost $2.46 Unrealized +2.3%
APPLIED THERAPEUTICS INC 1.2%
Value ($000) $7,242 Shares 5,658,034 Est. Cost $1.28 Unrealized
THESEUS PHARMACEUTICALS INC 1.1%
Value ($000) $7,184 Shares 770,000 Est. Cost $8.88 Unrealized
MIST MILESTONE PHARMACEUTICALS IN 1.0%
Value ($000) $6,295 Shares 2,208,812 Est. Cost $7.58 Unrealized -50.3%
ADVERUM BIOTECHNOLOGIES INC 1.0%
Value ($000) $6,179 Shares 3,886,246 Est. Cost $1.59 Unrealized
PRAXIS PRECISION MEDICINES I 1.0%
Value ($000) $6,100 Shares 5,304,410 Est. Cost $1.15 Unrealized
PLRX PLIANT THERAPEUTICS INC 0.8%
Value ($000) $5,236 Shares 288,949 Est. Cost $21.42 Unrealized +10.5%
LYRA THERAPEUTICS INC 0.6%
Value ($000) $3,798 Shares 924,170 Est. Cost $5.65 Unrealized
AEGLEA BIOTHERAPEUTICS INC 0.5%
Value ($000) $2,858 Shares 6,343,221 Est. Cost $0.45 Unrealized
BDTX BLACK DIAMOND THERAPEUTICS I 0.3%
Value ($000) $1,786 Shares 353,629 Est. Cost $2.04 Unrealized 0.0%
RALLYBIO CORP 0.2%
Value ($000) $1,520 Shares 268,532 Est. Cost $7.55 Unrealized
AFFIMED N V 0.1%
Value ($000) $855 Shares 1,428,571 Est. Cost $5.52 Unrealized
AVALO THERAPEUTICS INC 0.1%
Value ($000) $444 Shares 1,250,000 Est. Cost $1.47 Unrealized